Philpott-Howard, J. N., Wade, J. J., Mufti, G. J., Brammer, K. W., Ehniniger, G.
An open, randomized study was performed at 18 European centres to compare the efficacy, safety and tolerance of oral fluconazole with oral polyenes for the prophylaxis of fungal colonization and...
Richardson, K, Brammer, K W, Marriott, M S, Troke, P F
The therapeutic potential of UK-49,858, a difluorophenyl bis-triazole derivative, has been assessed by evaluating its activity against systemic infections with Candida albicans in normal mice and...
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Troke, P F, Andrews, R J, Brammer, K W, Marriott, M S, Richardson, K
UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an...
UK-38,006, 6 beta-iodopenicillanic acid, was shown to be a potent inhibitor of beta-lactamase enzymes. It potentiated the antibacterial action of ampicillin in vitro against beta-lactamase-producing...
In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic
Jevons, S., Cheeseman, H. E., Brammer, K. W.
The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli...
UK-18,892: Resistance to Modification by Aminoglycoside-Inactivating Enzymes
Andrews, R. J., Brammer, K. W., Cheeseman, H. E., Jevons, S.
UK-18,892, a new semisynthetic aminoglycoside, was active against bacteria possessing aminoglycoside-inactivating enzymes, with the exception of some known to possess AAC(6′) or AAD(4′) enzymes....
Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative
Jevons, S., Gymer, G. E., Brammer, K. W., Cox, D. A., Leeming, M. R. G.
Tioconazole (UK-20,349), a new antifungal imidazole derivative, was compared with miconazole for activity in vitro against Candida spp., Torulopsis glabrata, Cryptococcus neoformans, Aspergillus...
Richardson, K, Brammer, K W, Marriott, M S, Troke, P F
The therapeutic potential of UK-49,858, a difluorophenyl bis-triazole derivative, has been assessed by evaluating its activity against systemic infections with Candida albicans in normal mice and...
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Troke, P F, Andrews, R J, Brammer, K W, Marriott, M S, Richardson, K
UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an...
UK-38,006, 6 beta-iodopenicillanic acid, was shown to be a potent inhibitor of beta-lactamase enzymes. It potentiated the antibacterial action of ampicillin in vitro against beta-lactamase-producing...
In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic
Jevons, S., Cheeseman, H. E., Brammer, K. W.
The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli...
UK-18,892: Resistance to Modification by Aminoglycoside-Inactivating Enzymes
Andrews, R. J., Brammer, K. W., Cheeseman, H. E., Jevons, S.
UK-18,892, a new semisynthetic aminoglycoside, was active against bacteria possessing aminoglycoside-inactivating enzymes, with the exception of some known to possess AAC(6′) or AAD(4′) enzymes....
Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative
Jevons, S., Gymer, G. E., Brammer, K. W., Cox, D. A., Leeming, M. R. G.
Tioconazole (UK-20,349), a new antifungal imidazole derivative, was compared with miconazole for activity in vitro against Candida spp., Torulopsis glabrata, Cryptococcus neoformans, Aspergillus...